MedVellum
MedVellum
Back to Library
Ophthalmology
Emergency Medicine
Stroke Medicine
Neurology
EMERGENCY

Central Retinal Artery Occlusion

Moderate EvidenceUpdated: 2024-12-21

On This Page

Red Flags

  • Sudden painless monocular vision loss
  • Cherry-red spot on fundoscopy
  • RAPD
  • Giant cell arteritis symptoms
  • Cardiovascular risk factors
  • Atrial fibrillation
Overview

Central Retinal Artery Occlusion

Topic Overview

Summary

Central retinal artery occlusion (CRAO) is acute blockage of the central retinal artery, causing sudden, painless, profound monocular vision loss. It is the ocular equivalent of a stroke. The retina tolerates ischaemia for only 60-90 minutes before irreversible damage occurs. Classic fundoscopic finding is a "cherry-red spot" at the macula. CRAO is a marker for systemic vascular disease and requires urgent cardiovascular workup. Giant cell arteritis (GCA) must be excluded as it is a treatable cause.

Key Facts

  • Presentation: Sudden painless monocular vision loss (usually profound)
  • Fundoscopy: Pale retina with "cherry-red spot" at macula
  • Time-critical: Retina tolerates ischaemia for 60-90 minutes only
  • Aetiology: Embolic (carotid, cardiac) or arteritic (GCA)
  • Action: Urgent ophthalmology + exclude GCA + stroke/TIA workup

Clinical Pearls

"Eye stroke" = treat like brain stroke — urgent vascular workup

Always ask about GCA symptoms (headache, jaw claudication, scalp tenderness, polymyalgia)

Cherry-red spot = pale ischaemic retina surrounding normal choroidal circulation at fovea

Why This Matters Clinically

CRAO causes catastrophic, usually permanent vision loss. Acute treatment options are limited but may help in very early presentation. More importantly, CRAO is a marker for high-risk cardiovascular disease — the patient is at high risk of stroke and MI.


Visual Summary

Visual assets to be added:

  • Fundus photo showing cherry-red spot
  • Retinal artery anatomy
  • CRAO vs BRAO comparison
  • Cardiovascular workup algorithm

Epidemiology

Incidence

  • 1-2 per 100,000/year
  • Increases with age

Demographics

  • Mean age: 60-65 years
  • Male predominance
  • Associated with cardiovascular risk factors

Risk Factors

FactorNotes
Carotid artery diseaseEmbolic source
Atrial fibrillationCardiac embolism
Hypertension
Diabetes
Hyperlipidaemia
Smoking
Giant cell arteritisArteritic CRAO — treatable cause

Pathophysiology

Mechanism

  1. Occlusion of central retinal artery (or branch)
  2. Retinal ischaemia
  3. Inner retinal layers affected (supplied by CRA)
  4. Outer retina (photoreceptors) supplied by choroid — initially preserved

Causes of Occlusion

CauseNotes
EmbolicCarotid plaque, cardiac source (AF, valve disease)
ThromboticAtherosclerotic stenosis
Arteritic (GCA)Must exclude — treatable
VasospasmRare
HypercoagulableYounger patients

Cherry-Red Spot

  • Central fovea appears red (normal choroidal circulation)
  • Surrounded by pale, ischaemic retina
  • Classic sign

Time Window

  • Retina survives 60-90 minutes of complete ischaemia
  • After this, irreversible damage occurs

Clinical Presentation

Symptoms

Signs

GCA Symptoms (Must Ask)

Red Flags

FindingSignificance
GCA symptomsTreat immediately with high-dose steroids
BilateralGCA or embolic shower
Young patientConsider hypercoagulable state

Sudden painless monocular vision loss
Common presentation.
Usually profound (counting fingers or worse)
Common presentation.
May be transient initially (amaurosis fugax preceding)
Common presentation.
Clinical Examination

Visual Acuity

  • Severely reduced (counting fingers, hand movements, or light perception)

Pupil

  • RAPD present

Fundoscopy

  • Pale retina
  • Cherry-red spot
  • Attenuated arteries
  • Box-carring
  • May see embolus

Cardiovascular

  • Blood pressure
  • Carotid bruits
  • Heart rhythm (AF)

Investigations

Urgent — Exclude GCA

TestNotes
ESRElevated in GCA (often over 50)
CRPElevated
Platelet countOften elevated in GCA

If GCA suspected: Start high-dose steroids BEFORE temporal artery biopsy

Cardiovascular Workup

TestPurpose
ECGAtrial fibrillation
Carotid DopplerStenosis, plaque
EchocardiogramCardiac source of embolism
Fasting lipids, glucoseCardiovascular risk
Coagulation screenIf young or no risk factors

Fluorescein Angiography

  • Delayed or absent filling of retinal arteries
  • Not always performed in acute setting

Classification & Staging

By Extent

TypeDefinition
CRAOCentral retinal artery occlusion — total
BRAOBranch retinal artery occlusion — partial visual field loss

By Aetiology

  • Non-arteritic (embolic/thrombotic) — most common
  • Arteritic (GCA) — ophthalmic emergency

Management

Immediate — Within 90-120 Minutes (Limited Evidence)

InterventionNotes
Ocular massageMay dislodge embolus
Anterior chamber paracentesisReduces IOP, may improve perfusion
Carbogen inhalation95% O2 + 5% CO2; vasodilation
IV acetazolamideReduces IOP

Reality: Most patients present too late for these to be effective. Evidence for acute treatment is limited.

Urgent — Exclude GCA

ActionDetails
Ask GCA symptomsHeadache, jaw claudication, scalp tenderness
Check ESR, CRP
If GCA suspectedHigh-dose IV methylprednisolone 1g/day for 3 days
Then oral prednisolone60-80 mg/day; slow taper
Temporal artery biopsyWithin 2 weeks

Cardiovascular Secondary Prevention

ActionDetails
AntiplateletAspirin 75-300 mg
StatinHigh-intensity
BP control
Carotid interventionIf significant stenosis
AnticoagulationIf AF

Referral

  • Urgent ophthalmology
  • Stroke/TIA pathway (same risk as stroke)
  • Cardiology if cardiac source

Complications

Ocular

  • Permanent vision loss (most cases)
  • Rubeosis iridis (neovascularisation of iris) — weeks later
  • Neovascular glaucoma

Systemic

  • Stroke (high risk)
  • MI
  • Other thromboembolic events

Prognosis & Outcomes

Visual Prognosis

  • Poor — most patients do not recover useful vision
  • Better if cilioretinal artery present (spares macula)
  • BRAO has better prognosis than CRAO

Systemic Prognosis

  • 30% risk of stroke or cardiovascular event within 3 years
  • Treat cardiovascular risk factors aggressively

Evidence & Guidelines

Key Guidelines

  1. Royal College of Ophthalmologists Guidelines
  2. AAO Preferred Practice Pattern

Key Evidence

  • Acute treatments have limited evidence
  • Focus is on prevention of stroke and cardiovascular events
  • GCA requires immediate high-dose steroids

Patient & Family Information

What is CRAO?

CRAO is a blockage of the blood vessel that supplies your retina (the back of your eye). It causes sudden loss of vision in one eye.

Why Did This Happen?

  • Usually caused by a blood clot or plaque from the heart or arteries
  • Sometimes due to inflammation of blood vessels (GCA)

Will My Vision Come Back?

  • Unfortunately, vision usually does not recover
  • Treatment focuses on preventing problems in the other eye and preventing stroke

What Tests Will I Need?

  • Blood tests
  • Heart scan
  • Neck artery scan
  • Sometimes a biopsy of an artery near your temple

Resources

  • RNIB
  • Stroke Association

References

Key Reviews

  1. Hayreh SS. Central retinal artery occlusion. Prog Retin Eye Res. 2011;30(5):359-394. PMID: 21749659
  2. Biousse V, Newman NJ. Retinal and optic nerve ischemia. Continuum (Minneap Minn). 2019;25(5):1189-1210. PMID: 31584532

Guidelines

  1. AAO. Retinal and Ophthalmic Artery Occlusions Preferred Practice Pattern. 2019.

Last updated: 2024-12-21

At a Glance

EvidenceModerate
Last Updated2024-12-21
Emergency Protocol

Red Flags

  • Sudden painless monocular vision loss
  • Cherry-red spot on fundoscopy
  • RAPD
  • Giant cell arteritis symptoms
  • Cardiovascular risk factors
  • Atrial fibrillation

Clinical Pearls

  • "Eye stroke" = treat like brain stroke — urgent vascular workup
  • Always ask about GCA symptoms (headache, jaw claudication, scalp tenderness, polymyalgia)
  • Cherry-red spot = pale ischaemic retina surrounding normal choroidal circulation at fovea
  • **Visual assets to be added:**
  • - Fundus photo showing cherry-red spot

Guidelines

  • NICE Guidelines
  • BTS Guidelines
  • RCUK Guidelines